Drug Development Company Commercialising Topical Products for Global Markets

TITLE: Drug Development Company Commercialising Topical Products for Global Markets
GUEST: Michael Kotsanis
PRESENTER: Wayne Bucklar

OVERVIEW:
In today’s Health Supplier Segment, we are joined by Acrux Chief Executive Officer and Managing Director Michael Kotsanis to talk about their company’s background and drug delivery solutions. Acrux has successfully developed and licensed a number of pharmaceutical products in the US and Europe using the Patchless PatchTM, a fast-drying and invisible topical application technology. Marketed products include Axiron®, Evamist® and Lenzetto®. They also have a range of generic and patent-preferred products that are currently in development.

For more information about this interview, visit this link:
http://healthprofessionalradio.com.au/2016/04/01/health-supplier-segment-acrux/

source